Introduction {#s1}
============

The gastrointestinal (GI) tract of most metazoans, including that of humans, is lined by a series of highly compartmentalized epithelia that perform localized functions. These epithelia also share certain characteristics that support interactions with commensal bacteria (see [Box 1](#DMM024232B1){ref-type="boxed-text"} for Glossary), enhance immune responses to infections and maintain the barrier function of the intestine. These epithelia undergo regeneration in homeostatic conditions as well as in response to tissue damage. During recurring regenerative episodes, and for the lifetime of the animal, the functional diversity of newly formed intestinal cells has to be sustained -- an achievement that is only beginning to be understood, via the use of animal models ([@DMM024232C10]; [@DMM024232C29]; [@DMM024232C92]; [@DMM024232C103]; [@DMM024232C141]).

Conditions that negatively impact epithelial compartmentalization can have substantial deleterious consequences. In the human GI tract, for example, the development of epithelial metaplastic lesions (see [Box 1](#DMM024232B1){ref-type="boxed-text"}) can place individuals at a high risk of developing intestinal cancer ([@DMM024232C138]). In these lesions, one differentiated cell type is replaced by a cell with a different identity. One example is Barrett\'s metaplasia (see Box 1), in which the esophageal squamous epithelium acquires properties that are reminiscent of the gastric or intestinal columnar epithelium. This transformation has been associated with acid reflux disease and is believed to be a cause of esophageal adenocarcinomas ([@DMM024232C50]; [@DMM024232C67]). Dysplasia (see [Box 1](#DMM024232B1){ref-type="boxed-text"}), another type of epithelial lesion that commonly affects the human GI tract, is characterized by aberrant cell proliferation and differentiation. Dysplastic changes are often found at later stages during epithelial carcinogenesis than are metaplasias, and eventually lead to invasive carcinoma (see Box 1) ([@DMM024232C39]; [@DMM024232C148]). Much remains to be learnt about intestinal metaplasias and dysplasias, not least because of their clinical significance, such as the exact cellular origins of metaplastic cells and the molecular pathways that underpin epithelial dysfunction. Because intestinal epithelia are regenerated by local intestinal stem cell (ISC) populations, which have been characterized in the GI tract of flies and mice in the past decade ([@DMM024232C9]; [@DMM024232C105]; [@DMM024232C114]), deregulation of these stem cell functions, including proliferation and differentiation, has been associated with metaplastic and dysplastic lesions. To better understand the molecular changes underlying epithelial carcinogenesis, it is thus crucial to pinpoint the mechanisms that regulate ISC function.

In this Review, we highlight recent insights into the maintenance of GI compartmentalization and regulation of diverse stem cell lineages, focusing on advances made by analysis of the GI tract of *Drosophila* and mice. We then summarize findings about signaling pathways that control these stem cell functions, drawing parallels between the fly and mammalian systems. Finally, we discuss how these findings inform our current understanding of the pathogenesis of epithelial dysfunctions that can predispose humans to cancer.

GI tract compartmentalization and stem cell lineages {#s2}
====================================================

The GI tract of most metazoans is highly compartmentalized in terms of morphology and function, and regional epithelial subtypes are continuously regenerated by local stem cell populations. Both in the *Drosophila* and mouse GI tracts, studies are underway to characterize the identity, function and regulation of regionally specified stem cell populations and stem cell lineages. Below, we provide an overview of *Drosophila* and mammalian GI tract morphologies and their respective stem cell populations.

The *Drosophila* GI tract {#s2a}
-------------------------

The *Drosophila* GI tract is lined by a series of pseudostratified monolayer epithelia, which are surrounded by visceral muscle cells. Morphologically, the midgut, which is the main and best characterized part of the fly GI tract, is subdivided into the anterior midgut (AM), the middle midgut (MM) and the posterior midgut (PM) by two main constrictions ([Fig. 1](#DMM024232F1){ref-type="fig"}A). The MM contains a stomach-like copper cell region, which produces gastric acid, and a large flat cell region, the function of which is not well understood. Two recent studies have further divided the GI tract into 10-14 regions based on more detailed characterizations of morphological and molecular landmarks ([@DMM024232C29]; [@DMM024232C103]). ISCs are found in each of these compartments and can regenerate to give rise to all intestinal epithelial cell types ([Table 1](#DMM024232TB1){ref-type="table"}) ([@DMM024232C25]). Box 1. Glossary**Carcinoma:** a type of cancer that develops from epithelial cells.**Commensal bacteria:** normal microorganisms living on the surface or within the body of their host in a symbiotic relationship in which the host is benefited or unaffected.**Dysplasia:** an abnormality of development or an epithelial anomaly of growth and differentiation.**Gastric atrophy:** a condition in which the stomach shrinks owing to loss of gastric glandular cells.**Gastritis:** inflammation of the lining of the stomach.***Lgr5*-driven inducible Cre:** a technique used in mice in which Cre recombinase expression can be induced by a drug, most commonly tamoxifen, in LGR5-expressing cells and catalyzes DNA recombination at *loxP* sites either to delete one gene or to induce reporter gene expression for lineage tracing.**Metaplasia:** replacement of one differentiated cell type by another mature differentiated cell type.**Niche:** stem cell niche is a microenvironment that interacts with stem cells to regulate their function.**Organoids:** three-dimensional multicellular organs cultured *in vitro*.**Squamocolumnar junction:** the region connecting the esophageal squamous epithelium and the gastric columnar epithelium in the gastrointestinal tract.**Squamous keratinocytes:** cells found in the mucosa of the mouth and esophagus, as well as the corneal, conjunctival and genital epithelia, forming tight junctions and playing a role in immune system function.**Teratomas:** a tumor with tissue or organ components resembling normal derivatives of more than one germ layer.**Trans-differentiation:** direct conversion of one mature somatic cell to another mature somatic cell without going through an intermediate pluripotent state. Fig. 1.***Drosophila* and mammalian gastrointestinal (GI) tracts and associated stem cell lineages.** (A) A schematic of the *Drosophila* GI tract \['A', anterior, top; 'P', posterior, bottom), focusing on the midgut, which is divided into three main regions: the anterior midgut (AM), the middle midgut (MM) and the posterior midgut (PM). The MM contains an acidic stomach-like copper cell region (CCR) and a large flat cell region (LFC). (i) Organization of epithelial cells in the AM and PM (top), and the CCR (bottom). (ii) In the AM or PM, intestinal stem cells (ISCs) divide asymmetrically, giving rise to a new ISC and either a pre-enterocyte (pre-EC) enteroblast (EB), which will differentiate into an enterocyte (EC), or a pre-enteroendocrine-cell (pre-EE) EB, which will differentiate into an enteroendocrine cell (EE). (iii) In the CCR, gastric stem cells (GSSCs) undergo similar asymmetric division, giving rise to a new GSSC and two types of gastroblast (GB), which will differentiate into either a copper cell (CC), an interstitial cell (IS) or an EE. (B) The mammalian GI tract consists of an esophagus, stomach, small intestine and large intestine (not shown here) (anterior, top; posterior, bottom). (i) The murine stomach divides into three regions: forestomach, corpus and pylorus. The architecture of the gland unit, including the crypt, in the stomach corpus (right) and pylorus (left) is shown. Different stem cell populations (blue text) have been characterized, but exact stem cell lineages and cell hierarchies are unclear in these regions. (ii) In the murine small intestine, there are two main stem cell populations: +4 stem cells and LGR5+ stem cells, which can replace each other under certain conditions. A schematic of the crypt is shown on the left, and cell lineages are shown on the right. TA cells, transit amplifying cells. Table 1.**Cells in the mouse small intestine and *Drosophila* gastrointestinal tract**

The ISC lineage was first characterized in the PM by two groups simultaneously ([@DMM024232C105]; [@DMM024232C114]) ([Fig. 1](#DMM024232F1){ref-type="fig"}A). Numerous studies subsequently characterized the regulation of ISCs and their lineage relationship to their progeny. As discussed later, a multitude of local, paracrine and systemic signals and signaling pathways that control ISC proliferation and differentiation have been identified, and changes in ISC function during tissue damage and aging have been described ([@DMM024232C21]; [@DMM024232C28]; [@DMM024232C25]; [@DMM024232C72]; [@DMM024232C89]). ISCs \[characterized by expression of Escargot (Esg+) and Delta (Dl+)\] constitute the majority of cells capable of mitosis in the PM. During regenerative episodes, ISCs in the PM undergo asymmetric division to give rise to precursor cells, called enteroblasts \[which have the marker profile Esg+, Su(H)GBE+, Dl−\]. Enteroblasts further differentiate into either absorptive enterocytes \[ECs; Pdm1+ (also called nubbin or POU domain protein 1)\] or secretory enteroendocrine cells \[EEs; Prospero (Pros+)\] ([@DMM024232C105]; [@DMM024232C114], [@DMM024232C115]). Recent studies have refined our understanding of EE specification ([Fig. 1](#DMM024232F1){ref-type="fig"}A) ([@DMM024232C16]; [@DMM024232C18]; [@DMM024232C55]; [@DMM024232C160]; [@DMM024232C167]). *In vivo* lineage-tracing methods suggest that these cells are generated from pre-committed Pros-expressing ISCs, and not, as previously described, as an alternative to EC differentiation from a common enteroblast cell. EE regeneration from pre-committed Pros+ ISCs is limited by Slit, an EE-derived ligand for the roundabout 2 (Robo2) receptor. Slit binds Robo2 on ISCs, setting up a negative-feedback loop from differentiated EEs that limits further production of these cells ([@DMM024232C18]). A recent study shows that Ttk69, a BTB (broad complex, tramtrack and bric a brac)-domain-containing transcriptional repressor, also plays an important role in EE specification, presumably in parallel to Slit-Robo signaling ([@DMM024232C160]). Another study has further analyzed EE cell diversity and found that Su(H)GBE+ (Notch active) enteroblasts can give rise to class II EE cells, in addition to ECs ([@DMM024232C16]).

In the *Drosophila* copper cell region, which shares some similarity to the stomach in vertebrates, gastric stem cells (GSSCs; Esg+ and Dl+) generate three different cell types: copper cells, which secrete hydrochloric acid and are characterized by the marker profile Defective proventriculus (Dve)+/Labial(high)/Cut+; interstitial cells, defined by the profile Dve+/Labial(low)/Cut−; and Pros-expressing EEs ([@DMM024232C141]) ([Fig. 1](#DMM024232F1){ref-type="fig"}A). Similar to the ISC lineage in the PM, gastroblasts (the counterpart of the enteroblast in this region) have been identified and proposed to be the precursor cell that generates these three differentiated cell types ([@DMM024232C141]). Although ISCs in the AM are generally considered to be similar to ISCs in the PM, these two ISC populations have some different properties. For example, proliferation rates and expression of two genes (*Pdp1* and *Stat92E*) are different between AM and PM ISCs ([@DMM024232C103]). Using fluorescence-activated cell sorting (FACS) of ISCs from different regions of the *Drosophila* GI tract, a recent paper has systematically explored gene expression profiles of ISCs in a region-specific manner, and has characterized the roles of some transcription factors, such as GATAe (GATA is a family of transcription factors that are able to bind the DNA sequence 'GATA'), Snail (Sna; zinc-finger transcriptional repressor) and Ptx1 (paired-type homeobox transcription factor), in global and regional ISC regulation ([@DMM024232C48]). Future studies are needed to characterize in detail how the function of regional ISCs is regulated by these transcription factors, as well as by other potential molecular factors.

The mammalian GI tract {#s2b}
----------------------

In mammals, the structure of GI compartments (including the esophagus, gastric region, small intestine and colon) and the architecture of the epithelia lining these compartments are more complex than those of invertebrates ([Fig. 1](#DMM024232F1){ref-type="fig"}B). During recent years, specific markers of ISCs have been identified and new *in vivo* and *ex vivo* mouse models for exploring stem cell identity and function have been developed. As a result, our understanding of the regulation of epithelial homeostasis and of regeneration in the mammalian small intestine has improved substantially ([@DMM024232C8]; [@DMM024232C37]).

### The small intestine {#s2b1}

The lining of the small intestine is composed of a monostratified epithelium that folds into millions of tubular invaginations known as crypts ([Fig. 1](#DMM024232F1){ref-type="fig"}B), as well as into numerous finger-like protrusions called villi that project into the intestinal lumen, maximizing surface area for digestion and absorption. The crypts harbor stem cells, Paneth cells and transit amplifying (TA) cells, whereas the villi harbor three main differentiated cell types: ECs, goblet cells and EEs. Paneth cells at the base of the crypt are closely associated with stem cells, and secrete protective antimicrobial substances and the hydrolytic enzyme lysozyme, as well as niche (see Box 1) factors that are crucial for stem cell survival and function. Stem cells within the crypt self-renew and divide to generate TA cells, which in turn proliferate to generate all the functional differentiated cell types of the villi, maintaining tissue homeostasis. In contrast to *Drosophila* enteroblasts, which do not divide but differentiate directly into ECs or EEs, mouse TA cells undergo multiple rounds of cell division to amplify their numbers as they migrate along the crypt axis towards the base of the villus, where they differentiate into various functional cells ([Table 1](#DMM024232TB1){ref-type="table"}) ([@DMM024232C9]; [@DMM024232C22]; [@DMM024232C64]).

The existence of self-renewing and multipotent ISCs in crypts of the small intestine in mice had long been proposed, based on studies of mouse chimeras and the use of mutagen-induced somatic clones (genetically marked cells derived from a single epithelial cell) ([@DMM024232C22]; [@DMM024232C121]). However, the recent identification of ISC-specific markers has led to a substantial expansion of ISC studies in mammals ([@DMM024232C8]). Two different stem cell populations have been identified that express different markers and are positioned at different locations in the crypt: crypt base columnar (CBC) stem cells, which sit at the very base of the crypt, and +4 stem cells, which are located four cell diameters apical of the crypt base (see [Fig. 1](#DMM024232F1){ref-type="fig"}B). CBC stem cells in the adult small intestine express *LGR5* (Leu-rich repeat-containing G protein-coupled receptor 5) ([@DMM024232C9]), a Wnt target gene that also labels hair follicle epithelial stem cells, indicating that it might be a general marker for Wnt-activated stem cells ([@DMM024232C69]). Using *Lgr5-lacZ* and *Lgr5-EGFP* reporter mouse models, in which *lacZ* or *EGFP* expression is driven by the endogenous *Lgr5* promoter, Barker et al. found that LGR5 is specifically expressed in CBC cells at the crypt base, and that these LGR5+ CBC cells are evenly distributed between Paneth cells. The 'stemness' of LGR5+ CBC cells was confirmed using *in vivo* lineage tracing with an *Lgr5*-driven inducible Cre (see [Box 1](#DMM024232B1){ref-type="boxed-text"}) recombinase. Marked cells derived from LGR5+ CBC cells quickly grow into clones and expand to form epithelial cell clones that span from the crypt base to the tip of the villus and contain all major epithelial cell types ([@DMM024232C9]; [@DMM024232C36]).

BMI1, a Polycomb complex protein family member, marks +4 stem cells ([@DMM024232C130]). The expression pattern of BMI1 in the mouse intestine was first analyzed using RNA *in situ* hybridization, and its function as a marker of stem cells was confirmed using *in vivo* lineage tracing ([@DMM024232C130]). BMI1+ cells can self-renew, proliferate and generate all the different cell lineages of the small intestine, indicating that BMI1+ cells possess ISC identity. Further support for the function of BMI1+ cells as stem cells was provided by the specific ablation of BMI1+ cells from the crypt, which inhibited epithelial self-renewal and led to crypt loss ([@DMM024232C130]). Similar to LGR5+ cells, isolated BMI1+ cells can generate epithelial organoids (see [Box 1](#DMM024232B1){ref-type="boxed-text"}) in culture ([@DMM024232C165]). The co-existence but distinct localization of LGR5+ and BMI1+ stem cells suggests that more than one ISC population maintains long-term epithelial homeostasis and regeneration in the mammalian intestine, and that these populations might compensate for each other in certain conditions. Indeed, after the complete ablation of LGR5+ cells, BMI1+ cells can give rise to *Lgr5*-expressing cells and restore intestinal epithelial tissue ([@DMM024232C145]). It has been proposed that LGR5+ CBC stem cells are a more active population that is crucial for homeostatic epithelial renewal, whereas BMI1+ '+4' stem cells act as quiescent reserve stem cells that can be activated to restore tissue homeostasis after injury ([@DMM024232C8]). A recent study has provided molecular evidence to support this two-stem-cell model for epithelial regeneration in the mouse small intestine ([@DMM024232C94]); however, future studies are needed to further characterize the identity of ISC populations and their exact hierarchy.

In humans, epithelial cells from the base of colonic crypts have been purified using an antibody against a surface-expressed WNT target gene, EPH B2 receptor (*EPHB2*). These cells can be expanded *in vitro* and behave as multipotent stem cells ([@DMM024232C75]). In a more recent study, *Lgr5-GFP*-positive cells isolated from teratomas (see Box 1) derived from human pluripotent stem cells (hPSCs) generated uniform, long-lived intestinal organoids, thus demonstrating ISC properties ([@DMM024232C52]). This further indicates that ISC identity is conserved between mice and humans.

Although regeneration of the small intestine is thus better understood than regeneration of other compartments of the mammalian GI tract, recent studies have made headway in characterizing stem cell populations in the esophagus and stomach, as discussed below.

### The esophagus {#s2b2}

The esophagus, which connects the throat with the stomach, is lined by a stratified epithelium and lacks established niche structures, such as the crypts that are found in the small intestine. The epithelium consists of multiple layers of squamous keratinocytes (see [Box 1](#DMM024232B1){ref-type="boxed-text"}), with one layer of proliferating basal cells attached to the basement membrane and several layers of differentiated cells that are continuously shed into the lumen and replenished by cells generated at and migrating upward from the basal layer. Although esophageal stem cells are thought to exist in the basal layer, it remains unclear whether all basal cells or only a subpopulation have stem cell identity ([@DMM024232C70]). Studies using nucleotide label retention assays and a combination of cell markers have suggested that a portion of human and mouse esophageal basal cells are self-renewing and are long-lived stem cells ([@DMM024232C44]; [@DMM024232C76]; [@DMM024232C116]). However, pulse-chase experiments in mice using GFP-tagged histone H2B have shown that, although all epithelial cells are labeled after pulse labeling, no label-retaining cells remain in the esophageal epithelium after 4 weeks, indicating that the esophagus does not contain long-lived quiescent stem cells. Furthermore, fate mapping of basal cells using an inducible Cre-*lox* system suggests that all basal cells are functionally equivalent progenitors and that there are no long-lived cycling stem cells ([@DMM024232C45]). Additional studies are needed to clarify these conflicting findings.

### The stomach {#s2b3}

The mammalian stomach has three regions: the forestomach (in mice) or the cardiac region (in humans), the corpus and the pylorus ([Fig. 1](#DMM024232F1){ref-type="fig"}B). The corpus is the main component of the stomach. Its epithelium is composed of gastric units, crypt-like structures that project deep into the mucosa and can be subdivided into four regions based on distinct cell types. Close to the lumen are mucous cells in the pit region, under which the isthmus harbors fast-dividing stem cells. Below the isthmus is the neck region, which contains gland mucous cells, and at the base are chief cells, which secrete digestive enzymes. Acid-producing parietal cells are scattered throughout all regions. In the pylorus, the crypt-like gland unit is simpler, and in the base, the units contain a population of alkaline mucus-producing cells with few chief or parietal cells ([@DMM024232C107]).

The first stem cell population to be identified in the stomach, by morphology and labeling using thymidine analogs, maps to a highly proliferative zone of the isthmus ([@DMM024232C23]; [@DMM024232C86]; [@DMM024232C107]). Isthmus stem cells can give rise to each of the differentiated cell lineages, although their regulation has not been characterized in detail. It has been proposed that newly generated daughter cells from isthmus stem cells can undergo bidirectional migration: up to the pit to form surface mucus-secreting cells, and down to the base to form zymogenic chief cells through the neck ([@DMM024232C107]). In addition, these stem cells are thought to form acid-secreting parietal cells and hormone-secreting EEs along the pit-base axis ([Fig. 1](#DMM024232F1){ref-type="fig"}B). More recently, additional gastric stem cell populations have been identified in mice using Cre-based lineage-tracing methods in different gastric regions ([Fig. 1](#DMM024232F1){ref-type="fig"}B). Genetic labeling based on *Villin*-promoter--*Cre* (Cre recombinase driven by the *Villin* promoter) has identified a rare stem cell population at varying positions along the gland in the pylorus, which is quiescent in normal conditions and can regenerate all cell types during injury ([@DMM024232C122]). Other studies have identified a stem cell population at the base of the gland in the pylorus using *Lgr5-Cre*-based lineage tracing ([@DMM024232C11]), and a stem cell population in the pylorus and corpus near or under the isthmus region of the gland using *Sox2-Cre* ([@DMM024232C3]). It was further shown that differentiated Troy+ \[Troy is encoded by *Tnfrsf19*, and potentially functions as a receptor for lymphotoxin A ([@DMM024232C62])\] chief cells, which reside at the bottom of the gastric unit in the corpus, can act as reserve stem cells to regenerate all cell types over a longer period of time ([@DMM024232C140]). Together, these studies suggest that the gastric epithelium is highly plastic, and is maintained and regenerated by multiple stem cell populations. The exact lineage relationships between these cells, and how these stem cell populations are coordinated by local niche factors to meet demands during periods of regeneration, remains unclear.

Overall, our understanding of the organization of regenerative processes and of stem cell lineage relationships in the mammalian GI tract has made substantial progress in recent years. The dynamic control of GI stem cell activity during injury, either by infection or by tissue damage, has been explored and characterized in more detail in flies, and we summarize our current understanding of the dynamic regulation of stem cell activity in the following section.

Signaling pathways that control ISC proliferation and differentiation {#s3}
=====================================================================

The activity of stem cells along the GI tract needs to be specifically and dynamically regulated to adjust tissue turnover to local and tissue-wide needs. Numerous evolutionarily conserved signaling pathways have been identified to regulate these processes, both in flies and mice. In this section, we summarize our current understanding of the role of these pathways in ISC regulation under homeostatic and regenerative conditions ([Fig. 2](#DMM024232F2){ref-type="fig"}). Fig. 2.**Stem-cell-regulating signaling pathways in the *Drosophila* and mouse gastrointestinal (GI) tracts.** (A) Regulation of stem cell functions in the *Drosophila* GI tract. (i) In the *Drosophila* posterior midgut (PM), numerous signaling pathways (major pathways depicted) regulate stem cell proliferation, self-renewal and/or differentiation. (ii) In the stomach-like copper cell region (CCR), Wg, EGFR and Notch signaling pathways have similar roles in regulating stem cell functions as the same pathways in the PM, whereas Dpp signaling predominantly regulates stem cell differentiation. The roles of other signaling pathways identified in the CCR have not yet been determined (question mark). (B) Regulation of stem cell functions in the mouse GI tract. (i) In the mouse small intestine, BMP, Wnt, Notch and Hh signaling pathways are required to regulate stem cell functions. However, their roles in regulating stem cell functions in other regions, including the stomach and the esophagus (ii), are less well studied, especially in homeostatic conditions (question mark).

ISC proliferation and differentiation in *Drosophila* {#s3a}
-----------------------------------------------------

Signaling pathways that influence ISC proliferation and differentiation in *Drosophila* include Notch ([@DMM024232C115]), JAK/Stat ([@DMM024232C15]; [@DMM024232C73]; [@DMM024232C97]), Epidermal growth factor receptor (EGFR) ([@DMM024232C17]; [@DMM024232C27]; [@DMM024232C71]; [@DMM024232C74]), Insulin ([@DMM024232C34]; [@DMM024232C113]), Jun-N-terminal kinase (JNK) ([@DMM024232C19]), Wingless (Wg) ([@DMM024232C87]; [@DMM024232C96]), Target of Rapamycin (TOR) ([@DMM024232C1]; [@DMM024232C78]; [@DMM024232C123]), Decapentaplegic \[Dpp; the *Drosophila* homolog of bone morphogenetic protein (BMP)\] ([@DMM024232C7]; [@DMM024232C56]; [@DMM024232C93]; [@DMM024232C144]) and Hippo ([@DMM024232C79]; [@DMM024232C126]; [@DMM024232C139]) signaling. ISC differentiation is further controlled by Esg-mediated repression of Pdm1 ([@DMM024232C83]; [@DMM024232C99]) ([Fig. 2](#DMM024232F2){ref-type="fig"}A). The combined action of these signaling pathways influences proliferative activity, self-renewal and differentiation in the ISC lineage in response to a wide range of local and systemic cues. (For recent reviews that discuss the detail of ISC regulation by these signaling pathways, see [@DMM024232C21]; [@DMM024232C28]; [@DMM024232C25]; [@DMM024232C72]; [@DMM024232C89].) Recent work has also provided new insights into the integration of these diverse signals. For example, intracellular Ca^2+^ signaling is emerging as a central regulator of ISC proliferation in *Drosophila* in response to a wide range of mitogenic signals ([@DMM024232C43]).

The diversity of ISC responses to mitogenic signals along the GI tract remains poorly understood. To date, most studies characterizing the regulation of stem cell function in the *Drosophila* GI tract have focused on the PM. Stem cells in the AM (AM-ISCs), PM (PM-ISCs) and gastric region (GSSCs) share certain properties: all of them are positive for the general ISC marker Esg and can rapidly respond to stress-induced damage by increasing proliferative activity ([@DMM024232C21]; [@DMM024232C141]). PM-ISCs and GSSCs are also regulated in a similar fashion by several signaling pathways, including Wg, EGFR and Notch ([@DMM024232C141], [@DMM024232C142]; [@DMM024232C159]) ([Fig. 2](#DMM024232F2){ref-type="fig"}A). However, their responses to other signaling pathways are diverse. For example, lineage tracing has shown that the loss of Dpp signaling pathway components causes differentiation defects in GSSCs, but not in PM-ISCs ([@DMM024232C92]). Sustained Dpp expression along the GI tract is sufficient to induce ectopic copper cell formation in the AM, but not in the PM, indicating that additional regional determinants influence stem cell responses to Dpp signaling. Similarly, the strong activation of JAK/Stat signaling in GSSCs leads to their mis-differentiation, generating ectopic EC-like cells in the copper cell region ([@DMM024232C95]), whereas, in PM-ISCs, JAK/Stat activation induces proliferation but does not alter differentiation ([@DMM024232C73]) ([Fig. 2](#DMM024232F2){ref-type="fig"}A). The recent regionally segregated comparison of ISC gene expression profiles ([@DMM024232C48]) provides a powerful resource that could be used to identify potential factor(s) that specify regional stem cell identity and function in the *Drosophila* GI tract.

ISC proliferation and differentiation in mammals {#s3b}
------------------------------------------------

In the mammalian small intestine, ISC functions are maintained and regulated by factors from the stem cell niche (see [Box 1](#DMM024232B1){ref-type="boxed-text"}), which comprises adjacent epithelial cells, pericryptal myofibroblasts, enteric neurons, endothelial cells, intraepithelial lymphocytes and the basement membrane ([@DMM024232C157]). As in flies, ISC proliferation and differentiation is controlled by a multitude of signaling pathways, including Wnt, BMP, Hedgehog (Hh) and Notch ([Fig. 2](#DMM024232F2){ref-type="fig"}B) signaling ([@DMM024232C166]).

A gradient of Wnt activity forms along the crypt axis in the intestinal epithelium of both mice and humans, with the highest activity at the crypt base, decreasing toward the villus ([@DMM024232C84]; [@DMM024232C150]). Wnt signaling is critically important for adult ISC proliferation ([@DMM024232C82]), and loss of Wnt signaling in adult mice, via the genetic deletion of β-catenin ([@DMM024232C51]), the overexpression of the Wnt antagonist Dkk1 ([@DMM024232C85]; [@DMM024232C119]) or by the deletion of the Wnt/TCF4 target gene *Myc* ([@DMM024232C109]), leads to complete ablation of intestinal crypts. Wnt signaling further determines cell fates within and the spatial organization of the crypt ([@DMM024232C132]). High Wnt activity in non-proliferating Paneth cells is required for their terminal differentiation ([@DMM024232C2]; [@DMM024232C153]), and this effect is mediated by the Wnt target gene *Sox9* ([@DMM024232C12]; [@DMM024232C13]; [@DMM024232C108]).

A gradient of BMP signaling activity also forms along the crypt-villus axis in mouse and human intestines ([@DMM024232C151]), but this gradient is reversed in relation to Wnt signaling ([@DMM024232C59]; [@DMM024232C60]; [@DMM024232C63]; [@DMM024232C84]). Deletion of BMP receptor 1a leads to the expansion of proliferative stem cells and progenitor cells ([@DMM024232C63]), and inhibition of BMP signaling results in the formation of ectopic crypts ([@DMM024232C59]), indicating that BMP signaling negatively regulates ISC proliferation and self-renewal, potentially by inhibiting Wnt signaling ([@DMM024232C63]). These two pathways might also be influenced by Hh signaling, because constitutive activation of Hh signaling by inactivating the receptor patched1 (*Ptch1*) increases BMP signaling and reduces Wnt signaling activity in the adult mouse intestine, resulting in reduced epithelial precursor cells and in the premature differentiation of ECs ([@DMM024232C152]). Accordingly, inhibiting Hh signaling \[Sonic hedgehog (*Shh*) and Indian hedgehog (*Ihh*)\] results in defective villus formation and in a hyperproliferative epithelium ([@DMM024232C100]). In the *Drosophila* hindgut (the posterior part of the GI tract after the midgut), stem cell self-renewal is maintained by Wg signaling, and Hh signaling is required for these cells to exit the cell cycle and differentiate, suggesting that the interaction between Hh and Wg is conserved across organisms ([@DMM024232C143]).

Notch signaling, in turn, seems to have acquired a different function in the mammalian ISC lineage, maintaining the proliferative state of stem and progenitor cells rather than promoting differentiation as it does in flies ([@DMM024232C151]) ([Fig. 2](#DMM024232F2){ref-type="fig"}B). The inhibition of Notch signaling in the mouse small intestine leads to cell cycle arrest of proliferative crypt cells and to the rapid conversion of all epithelial cells into secretory goblet cells ([@DMM024232C106]; [@DMM024232C154]; [@DMM024232C164]). A recent study has shown that blocking Notch signaling using antibodies against Notch receptors in the mouse small intestine leads to the conversion of LGR5+ ISCs into secretory cells. This perturbation is mediated by de-repression of the Wnt signaling pathway, demonstrated by the findings that Notch inhibition leads to activation of Wnt signaling and attenuation of the Wnt pathway rescues phenotypes induced by inhibitory antibodies against Notch ([@DMM024232C146]). Ectopic activation of Notch in the mouse small intestine, on the other hand, results in the expansion of proliferative compartments of the crypt, and inhibits the generation of secretory cell types, including goblet cells, EEs and Paneth cells ([@DMM024232C53]). In the fly, a recent study suggests that bi-directional Notch signaling plays a role in maintaining ISC fates in asymmetric divisions in the PM that give rise to EEs, suggesting that some aspects of the function of Notch signaling are conserved between flies and vertebrates ([@DMM024232C55]).

As in the fly, stem cells in different regions of the mammalian GI tract have distinct regional characteristics, allowing them to respond in unique ways to signals to meet local needs. For example, *Lgr5*-expressing stem cells can be found throughout the small intestine and in the pyloric region of the stomach, but not in the main body of the stomach (corpus) ([@DMM024232C11]), nor in the normal esophageal epithelium ([@DMM024232C156]). This suggests that stem cells along the mammalian GI tract might be differentially regulated by Wnt signaling. In the stomach, stem cells in different regions show a large amount of diversity: Wnt signaling is required to maintain basal stem cells in the distal pyloric region ([Fig. 1](#DMM024232F1){ref-type="fig"}B) ([@DMM024232C11]), whereas *Lgr5*-negative basal stem cells in the stomach corpus express Troy and exhibit different levels of Wnt activity compared to *Lgr5*-positive pyloric stem cells ([@DMM024232C140]) ([Fig. 1](#DMM024232F1){ref-type="fig"}B). This diversity is further illustrated by the fact that constitutive Notch activation in multipotent progenitors of the corpus significantly increases cell proliferation, leading to adenoma formation, whereas Notch activation in pyloric *Lgr5*-positive stem cells results in normal cell proliferation ([@DMM024232C81]).

Overall, the regulation of stem cell function in the mammalian stomach and esophagus in homeostatic conditions remains poorly understood. This is partially due to the earlier mentioned debate concerning stem cell identities in the esophagus, but is also due to a lack of stem-cell-specific markers in both the esophagus and stomach. As stem cell markers and stem cell lineages are identified for these gastric regions and explored in detail, we anticipate that the regulation of these cell populations by conserved signaling pathways will become clearer ([Fig. 2](#DMM024232F2){ref-type="fig"}B).

Although recent studies have provided new information on the regulation of stem cell function by different signaling pathways both in *Drosophila* and mouse GI tracts, several interesting questions remain and warrant further exploration. For example, how are multiple signaling pathways integrated in stem cells to trigger the appropriate response, how do stem cells coordinate symmetric and asymmetric divisions to meet local epithelial needs during regeneration, and how do epithelial environments differentially regulate the plasticity of stem cells and differentiated cells \[for example, when does trans-differentiation (see [Box 1](#DMM024232B1){ref-type="boxed-text"}) occur\]? Owing to the simplicity of epithelial structures and the availability of powerful genetic tools, the *Drosophila* GI tract provides an important tool in which to address these questions. It can be anticipated that resolving these open questions will provide important insight not only into physiological regenerative processes, but will also improve our understanding of the origin and progression of proliferative dysfunctions in the GI tract, including the development of cancerous lesions. Our understanding of the development of metaplasias and dysplasias in the GI tract of flies and mammals has greatly advanced in recent years, and is summarized in the following section.

Metaplasia and dysplasia: understanding molecular mechanisms {#s4}
============================================================

Advances in our understanding of the behavior and regulation of GI stem cells under homeostatic conditions have also shed new light on the origin and progression of epithelial disorders in the GI tract. Metaplasia and dysplasia refer to two types of tissue lesions (see [Box 1](#DMM024232B1){ref-type="boxed-text"}) that are associated with epithelial carcinogenesis ([@DMM024232C138]; [@DMM024232C148]). These lesions are associated with aberrant cell proliferation and differentiation, which eventually leads to loss of tissue homeostasis. A tremendous number of clinical studies have focused on the epidemiology and pathogenesis of intestinal metaplasia and dysplasia in humans ([@DMM024232C39]; [@DMM024232C61]; [@DMM024232C77]), and studies in animal models, including in mice and flies, have greatly expanded our knowledge of the mechanisms that cause these lesions at the cellular and molecular level ([@DMM024232C92]; [@DMM024232C98]; [@DMM024232C102]; [@DMM024232C124]). In the closing sections of this Review, we discuss these studies particularly in the context of our emerging understanding of how intrinsic and extrinsic factors cause GI epithelial dysfunction, and how dysregulation of GI stem cells is related to these lesions.

Metaplasia in the mammalian GI tract {#s4a}
------------------------------------

Metaplasias are defined as the replacement of one differentiated cell type by another in a potentially reversible manner. Metaplasias are most likely to occur in epithelial tissues that are frequently exposed to environmental insults and that need to regenerate for tissue repair, such as the airway, the esophagus and the stomach ([@DMM024232C138]). These changes often predispose individuals to the development of cancer ([@DMM024232C138]). Smokers, for example, often exhibit squamous metaplasia in the normally columnar-cell-lined bronchi, and these metaplastic sites are believed to be the site of origin of lung cancers ([@DMM024232C4]).

Two of the most common metaplasias that affect the mammalian GI tract are Barrett\'s esophagus (affecting the esophagus) and intestinal metaplasia (occurring in the gastric region) ([Fig. 3](#DMM024232F3){ref-type="fig"}A). The normal esophagus is lined by multiple layers of squamous cells, which, in Barrett\'s esophagus, become column-shaped such that the distal esophageal epithelium is eventually replaced by a stomach- or intestine-like columnar epithelium ([@DMM024232C50]). Barrett\'s esophagus is strongly associated with gastro-esophageal reflux disease ([@DMM024232C131]; [@DMM024232C163]), and is the most important risk factor for esophageal adenocarcinoma, especially when dysplastic changes occur in the later stages of the condition ([@DMM024232C67]). Current treatment options for Barrett\'s esophagus include aggressive inhibition of stomach acid production, anti-reflux surgery, chemoprevention and ablation therapy, but there is still no agreement on an optimal treatment or prevention route ([@DMM024232C124]). This is partly due to a lack of knowledge of the exact cellular origins of this condition in humans. Recent studies of mouse models of Barrett\'s-like metaplasia have implicated several types of cell, including LGR5+ stem cells, which originate in the cardiac region and migrate proximally into the esophagus in response to pro-inflammatory stimuli ([@DMM024232C125]), carbonic anhydrase 4 (CAR4)+/keratin 7 (KRT7)+ residual embryonic cells that expand proximally into the esophagus from their normal postnatal position at the squamocolumnar junction (see [Box 1](#DMM024232B1){ref-type="boxed-text"}) ([@DMM024232C158]), and cells of the submucosal gland ducts that expand and have been shown to generate Barrett\'s esophagus ([@DMM024232C88]). It is also possible that normal esophageal stem cells within the basal layer change their identity and give rise to Barrett\'s metaplasia. A better characterization of esophageal stem cells and of cell lineage hierarchy would help to test this hypothesis. Fig. 3.**Metaplasia and dysplasia in the human and *Drosophila* gastrointestinal (GI) tract.** (A) GI pathologies in humans ('A', anterior, top; 'P', posterior, bottom). Barrett\'s esophagus (left) is a metaplastic lesion, in which the distal esophageal epithelium (see red arrowhead) is replaced by a stomach- or intestine-like columnar epithelium. Gastric metaplasia (right) is another common metaplastic disease in the human GI tract, in which intestinal epithelial cells (see green arrowhead) are found in the stomach. Gastric metaplasia can develop further into dysplasia (far right, depicted in red), characterized by atypical changes of the epithelial structure due to aberrant cell proliferation and differentiation. (B) GI pathologies in *Drosophila*. (i) Metaplasia in the *Drosophila* anterior midgut (AM) is characterized by ectopic generation of copper cells (CCs), normally restricted to the middle midgut (MM) in homeostatic conditions, in the AM. The schematic on the left summarizes the replacement of AM cells by MM cells (depicted in yellow) during metaplasia. PM, posterior midgut. The images on the right were obtained by immunostaining (using an antibody specific for Cut, a marker for CCs) and confocal microscopy of the midgut region in flies. Dpp overexpression (right-hand panel) generates ectopic acid-producing CCs, indicative of metaplasia (see main text for further details). Scale bars: 100 μm. Microscopy images adapted from [@DMM024232C92]). (ii) Dysplasia in the *Drosophila* midgut is characterized by stem cell over-proliferation and abnormal differentiation. The schematic on the left summarizes changes of the epithelial structure during dysplasia. The images on the right were obtained from confocal microscopy of the posterior midgut (blue, DAPI; green, GFP). The stem/progenitor cell marker *esg\>GFP* (*esg::Gal4, UAS::GFP*) is only expressed in intestinal stem cells (ISCs) and enteroblasts (EBs) during homeostasis, whereas, in the dysplastic condition, *esg\>GFP* begins to be expressed in differentiated cells, including enterocyte (EC)-like cells and enteroendocrine cells (EEs). Scale bars: 25 μm.

Intestinal metaplasia, another common lesion in the human GI tract, is characterized by the presence of intestinal epithelial cells in the stomach ([@DMM024232C38]). Gastric carcinogenesis often follows a phenotypic path that includes intestinal metaplasia, and that also features gastritis, gastric atrophy, dysplasia and carcinoma (see [Box 1](#DMM024232B1){ref-type="boxed-text"}). Two stages of metaplasia can be distinguished: complete intestinal metaplasia in the initial phase, where the metaplastic epithelium resembles the mucosa of the small intestine and is lined by absorptive ECs and goblet cells; and incomplete intestinal metaplasia in later stages, where the metaplastic epithelium acquires the morphological features of the large intestine and is lined only by goblet cells ([@DMM024232C39]). In both cases, the gastric region starts to express the intestinal marker mucin 2 (MUC2), whereas the gastric marker mucin 6 (MUC6) is lost ([@DMM024232C118]). Intestinal metaplasia sometimes continues to develop into dysplasia (see details below) in the gastric region, which can eventually lead to gastric cancer.

Infection by the bacterium *Helicobacter pylori* is the leading cause of gastric cancer, and it is believed that a combination of bacterial virulence factors, environmental insults and the host inflammatory response drive the initiation of gastritis, which can progress to intestinal metaplasia ([@DMM024232C39]). Epidemiological studies have reported the beneficial effects of eradicating *H. pylori* for the prevention of gastric cancer development ([@DMM024232C41]; [@DMM024232C90]; [@DMM024232C104]; [@DMM024232C147]). However, the underlying mechanisms of *H. pylori*-driven carcinogenesis and the origins of the metaplastic cells involved remain elusive. Studies in mouse models suggest that *H. pylori*-induced carcinogenesis is associated with chronic inflammation ([@DMM024232C162]), that infection causes the loss of cells that are important for the appropriate maturation of gastric precursor cells ([@DMM024232C91]), and that infection increases cell proliferation rates ([@DMM024232C31]). Using lineage-tracing approaches, one study has shown that bone-marrow-derived cells can be a source of intestinal metaplasia and gastric cancer ([@DMM024232C66]). How marrow-derived cells are transformed into metaplastic cells remains unclear, and it cannot be ruled out that local gastric stem cells are reprogrammed by the altered immune environment, switch to an intestine-like proliferation/differentiation mode and then generate metaplastic tissue ([@DMM024232C39]). More precise characterization of stem cell markers and cell lineages in the gastric region are expected to advance future studies that test this hypothesis.

Dysplasia in the mammalian GI tract {#s4b}
-----------------------------------

Dysplasia is characterized by the acquisition of an epithelial structure that has no counterpart in the healthy body ([@DMM024232C138]). During carcinogenesis, dysplasias are found at the neoplastic stage ([@DMM024232C129]), and their rate of progression to invasive carcinomas is very high, both in the gastric region and in the colon ([@DMM024232C42]; [@DMM024232C129]; [@DMM024232C148]). Dysplasias can be classified into low-grade and high-grade dysplasia, depending on the severity of cellular abnormalities ([@DMM024232C68]). Precancerous metaplastic lesions transition to dysplasias at a relatively slow pace, but the rate of progression can vary, and can be higher in older individuals ([@DMM024232C40]; [@DMM024232C39]). Furthermore, it is believed that this transition is not a one-way process, because more-advanced lesions can regress to less-advanced lesions ([@DMM024232C40]). However, once dysplastic cells cross the basal membrane of the stomach, they become invasive gastric carcinomas, which can be lethal. Dysplasias in the colon are often seen as precursor lesions of colorectal cancer, which accounts for about 10% of all cancers throughout the world ([@DMM024232C133]; [@DMM024232C148]). Proctocolectomy, a surgical technique to remove the rectum and all or part of the colon, is therefore often recommended for cases in which dysplasias are detected in the colon ([@DMM024232C68]).

Colorectal cancer is strongly associated with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn\'s disease ([@DMM024232C120]). A series of molecular alterations in epithelial cells, including mutations of the Wnt signaling suppressor adenomatosis polyposis coli (*APC*), the tumor suppressor gene *p53*, and the *k-ras* oncogene, drive the development of dysplasia or colorectal cancer from colitis in individuals with IBD ([@DMM024232C68]; [@DMM024232C5]; [@DMM024232C24]; [@DMM024232C30]; [@DMM024232C80]; [@DMM024232C112]). Inflammatory cells contribute to cancer progression by supplying growth and survival factors that sustain proliferation and limit cell death, and by releasing reactive oxygen species (ROS) that perturb genome maintenance ([@DMM024232C54]; [@DMM024232C58]). Chronic inflammation, a hallmark of IBD, is thus a critical contributory factor to the molecular changes that drive the progression of colorectal cancer. In addition, recent studies have linked the development of IBD as well as the susceptibility of colitis-associated colorectal cancer to alteration of the intestinal microbiota ([@DMM024232C101]; [@DMM024232C149]), which could modulate host immune function to favor disease development ([@DMM024232C137]; [@DMM024232C155]).

Both metaplasia and dysplasia involve the transformation or trans-differentiation of epithelial cells, a process that likely involves changes in the transcriptional programs that establish and maintain cell identities. Indeed, the homeodomain transcription factors *Cdx1* and *Cdx2* have been implicated in changes in GI compartmentalization in mice. During embryonic development, *Cdx1* and *Cdx2* define prospective intestinal cells, but are excluded from prospective stomach regions ([@DMM024232C38]). This expression pattern is maintained in the adult GI tract and is required to maintain the segregation of different compartments ([@DMM024232C14]). Intestinal metaplasia in the human stomach is associated with ectopic expression of CDX genes ([@DMM024232C134]), and the forced expression of *Cdx2* using a stomach-specific promoter in mice is sufficient to generate intestinal tissues in the stomach ([@DMM024232C110]; [@DMM024232C135]). In the mouse intestine, loss of *Cdx2* leads to the formation of a squamous epithelium that resembles the esophagus ([@DMM024232C14]), whereas, in Barrett\'s esophagus, *Cdx2* is ectopically expressed in metaplastic cells ([@DMM024232C49]). Furthermore, the overexpression of *Cdx2* and bone morphogenetic protein 4 (*Bmp4*) induces the expression of intestinal genes in the mouse esophagus ([@DMM024232C102]), whereas activation of two transcription factors, *Sox2* and *Stat3*, transforms basal progenitor cells into malignant cells, causing squamous cancer ([@DMM024232C98]). These studies suggest that deregulation of crucial transcription factors or growth factor pathways triggers a cascade of events that eventually lead to metaplasia and dysplasia.

The development of metaplasias and dysplasias is tightly linked to deregulation of GI stem cell function, and gaining a deeper understanding of the regulation of stem cell activity, identity and maintenance is crucial if we are to understand the origin and progression of these pathologies. Work in the *Drosophila* GI tract has made substantial progress towards this goal, as highlighted below.

Metaplasia and dysplasia in the *Drosophila* GI tract {#s4c}
-----------------------------------------------------

The adult *Drosophila* GI tract is emerging as a powerful model in which to explore in mechanistic detail the origin and progression of metaplasias and dysplasias as a consequence of dysfunctions in ISC biology, microbe-host interactions and epithelial deregulation ([@DMM024232C21]; [@DMM024232C89]). During aging or after a pathogenic infection, compartmentalization of the GI tract is disturbed, as revealed by a strong alteration in gene expression patterns in these two conditions ([@DMM024232C29]). However, signaling mechanisms that maintain compartment identities are only beginning to be understood. Dpp signaling activity forms a gradient near the boundary between the MM and the PM. This gradient seems to segregate stem cell identities in those two regions ([@DMM024232C56]; [@DMM024232C92]). Ectopic and chronic activation of Dpp signaling in the AM can lead to the aberrant development of copper cells, which are normally restricted to the MM, in this region; a metaplasia similar to Barrett\'s esophagus in humans ([@DMM024232C92]) ([Fig. 3](#DMM024232F3){ref-type="fig"}B). Interestingly, this metaplasia is only observed when Dpp is overexpressed in ECs using a strong EC driver ([@DMM024232C92]), and not when it is expressed using a visceral muscle driver ([@DMM024232C46]), indicating that the source and/or strength of the Dpp signal determines the response of AM cells. Metaplasia induced by Dpp overexpression in the AM is mediated by the downstream transcription factor Labial ([@DMM024232C92]), which also plays an important role in GI compartmentalization in the larval stage, specifically for MM development ([@DMM024232C111]), similar to the role of CDX genes in mammals. Metaplasias thus seem to be driven by the ectopic activation of developmental pathways in the adult. This metaplasia is not seen in the PM, supporting the notion that ISCs in different regions of the GI tract possess distinct characteristics. It is possible that 'pan-ISC' transcription factors along the GI tract determine a general stem cell identity, and region-specific transcription factors further refine stem cell properties. The analysis of regional ISC gene expression profiles and of regional properties of ISCs by lineage tracing supports this notion ([@DMM024232C47]; [@DMM024232C103]).

Dysplasia is a common age-related dysfunction of the *Drosophila* GI tract ([Fig. 3](#DMM024232F3){ref-type="fig"}B). In aging flies, ISCs become hyper-proliferative, leading to the accumulation of mis-differentiated cells that co-express stem and progenitor cell markers (such as Dl and Esg), and differentiation markers (such as Notch signaling activity and polyploidy) ([@DMM024232C19]; [@DMM024232C26]; [@DMM024232C65]). These dysplastic changes can result in epithelial barrier dysfunction, which is strongly associated with fly death ([@DMM024232C128]). Age-related intestinal dysplasia is caused by increased JNK and/or Platelet-derived growth factor (PDGF)/Vascular endothelial growth factor (VEGF) signaling activity in the aging intestine ([@DMM024232C19]; [@DMM024232C33]). In response to oxidative stress or pathogenic infection, JNK signaling and JNK-mediated cytokine/JAK/Stat signaling can also be chronically activated in *Drosophila*, leading to similar dysplastic phenotypes ([@DMM024232C19]; [@DMM024232C26]; [@DMM024232C65]). In addition, a recent study shows that dysregulation of ISC niche signals, including EGFR ligands and cytokines that activate JAK/Stat signaling, contribute to the development of dysplasia and tumorigenesis from Notch-defective ISCs ([@DMM024232C117]). Furthermore, defects in endocytic degradation can cause intestinal dysplasia ([@DMM024232C168]).

A number of factors that contribute to dysplasia in the aging intestine, including a decline of mitochondrial function in stem and progenitor cells, dysbiosis of gut commensals, inflammatory signals from the fat body, increased endoplasmic reticulum (ER) stress and frequent somatic mutation in ISCs in the intestinal epithelium, have now been identified ([@DMM024232C32]; [@DMM024232C35]; [@DMM024232C57]; [@DMM024232C127]; [@DMM024232C136]; [@DMM024232C161]). Limiting age-related dysplastic changes by genetically manipulating ISCs to avoid hyper-proliferation is sufficient to extend *Drosophila* lifespan ([@DMM024232C20]). Understanding the underlying mechanisms that contribute to age-related dysplasia is thus likely to help identify interventions that not only improve intestinal function, but also benefit the health of the whole organism. Several interventions that specifically target these factors have been shown to extend the lifespan of flies reared under laboratory conditions ([@DMM024232C6]; [@DMM024232C32]; [@DMM024232C35]; [@DMM024232C57]; [@DMM024232C127]; [@DMM024232C161]).

Conclusions and perspectives {#s5}
============================

It is clear that a large number of parallels can be drawn between stem cell function and regulation, as well as the control of regenerative processes, in the GI tract of flies and mammals. The rich mechanistic insight provided by the fly system is thus expected to complement studies made in mice to enhance our understanding of stem cell function in the GI tract of humans. Moreover, the evolutionary conservation of regenerative processes in different regions of invertebrate and vertebrate GI tracts indicate that current research on the origin of pathological dysfunctions in *Drosophila* GI epithelia will generate important insight into human pathologies. *Drosophila* research benefits from the short lifespan, relative genetic, morphological and functional simplicity, and experimental accessibility of the model. Crucially, the sophisticated genetic tools available for spatiotemporally controlled genetic perturbations and for selective lineage tracing enable rigorous characterization of the genetic control of regeneration in both homeostatic and pathological conditions. Given the advances made so far, we anticipate that studies using *Drosophila* will soon provide insight that will inform the development of targeted interventions to prevent or treat human pathologies of the GI tract.
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